11:39 AM EST, 11/06/2025 (MT Newswires) -- (Updates to include Haemonetics' ( HAE ) recent stock movement in the headline and first paragraph.)

Haemonetics ( HAE ) shares were up more than 28% in recent Thursday trading after the company posted fiscal Q2 results that topped expectations.

The company reported adjusted earnings of $1.27 per diluted share, compared with $1.12 a year earlier.

Two analysts surveyed by FactSet expected $0.99.

Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier.

Analysts surveyed by FactSet expected $311.5 million.

The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.

Price: 64.36, Change: +13.64, Percent Change: +26.89